US Stock MarketDetailed Quotes

GOVX GeoVax Labs

Watchlist
  • 2.6400
  • -0.0700-2.58%
Close Nov 29 13:00 ET
  • 2.6700
  • +0.0300+1.14%
Post 17:01 ET
24.91MMarket Cap-314P/E (TTM)

GeoVax Labs Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-82.45%-9.3M
67.85%-1.94M
-51.05%-5.68M
-32.28%-25.17M
-45.49%-10.28M
-34.13%-5.1M
-57.48%-6.04M
13.16%-3.76M
-69.97%-19.03M
-5.70%-7.06M
Net income from continuing operations
30.84%-5.82M
14.57%-5.06M
-44.88%-5.85M
-85.20%-25.97M
-41.02%-7.59M
-111.91%-8.41M
-164.43%-5.93M
-66.34%-4.04M
24.50%-14.02M
60.83%-5.38M
Depreciation and amortization
75.58%30.41K
37.10%23.74K
13.03%19.58K
31.78%74.17K
57.86%22.21K
-2.01%17.32K
41.15%17.32K
41.16%17.32K
46.11%56.28K
20.11%14.07K
Change In working capital
-221.49%-3.64M
856.29%3M
-193.36%-10.91K
94.03%-356K
-52.61%-2.97M
3,534.27%3M
78.12%-396.36K
100.55%11.69K
-186.14%-5.97M
-128.09%-1.95M
-Change in receivables
---246.9K
----
----
--0
--0
--0
----
----
-63.33%49.01K
--0
-Change in prepaid assets
3,134.20%251.81K
96.52%112.39K
10.44%-677.03K
90.18%-114.49K
590.40%592.6K
97.34%-8.3K
107.14%57.19K
-446.35%-755.97K
-7,064.75%-1.17M
169.64%85.83K
-Change in payables and accrued expense
-222.05%-3.66M
752.91%2.96M
-3.42%-215.97K
54.31%-1.23M
-74.47%-3.56M
110.77%3M
-240.41%-453.54K
89.20%-208.84K
-139.46%-2.69M
-128.75%-2.04M
-Change in other current assets
0.00%10K
--224.68K
-9.67%882.1K
145.60%986.5K
--0
100.84%10K
--0
--976.5K
---2.16M
--10K
Cash from discontinued investing activities
Operating cash flow
-82.45%-9.3M
67.85%-1.94M
-51.05%-5.68M
-32.28%-25.17M
-45.49%-10.28M
-34.13%-5.1M
-57.48%-6.04M
13.16%-3.76M
-69.97%-19.03M
-5.70%-7.06M
Investing cash flow
Cash flow from continuing investing activities
-233.54%-20.65K
63.54%-48.95K
-18.95K
88.06%-6.19K
-181.36%-134.26K
0
Net PPE purchase and sale
-233.54%-20.65K
----
----
63.54%-48.95K
---18.95K
88.06%-6.19K
----
----
-181.36%-134.26K
--0
Cash from discontinued investing activities
Investing cash flow
-233.54%-20.65K
----
----
63.54%-48.95K
---18.95K
88.06%-6.19K
----
----
-181.36%-134.26K
--0
Financing cash flow
Cash flow from continuing financing activities
16.35M
-88.51%4.06M
4.06M
0
176.54%35.35M
0
Net issuance payments of debt
---150K
----
----
----
----
--0
----
----
----
----
Net common stock issuance
--15.52M
----
----
--0
--0
--0
----
----
194.69%27.73M
--0
Proceeds from stock option exercised by employees
--977.77K
----
----
-46.73%4.06M
--4.06M
--0
----
----
124.02%7.63M
--0
Cash from discontinued financing activities
Financing cash flow
--16.35M
----
----
-88.51%4.06M
--4.06M
--0
----
----
176.54%35.35M
--0
Net cash flow
Beginning cash position
-91.22%1.56M
-96.78%768.86K
-76.63%6.45M
141.71%27.61M
-63.41%12.69M
-42.44%17.79M
46.70%23.85M
141.71%27.61M
15.58%11.42M
91.51%34.68M
Current changes in cash
237.81%7.03M
113.08%792.85K
-51.05%-5.68M
-230.71%-21.16M
11.75%-6.23M
-235.17%-5.1M
-141.39%-6.06M
-177.84%-3.76M
951.17%16.19M
-5.70%-7.06M
End cash Position
-32.27%8.59M
-91.22%1.56M
-96.78%768.86K
-76.63%6.45M
-76.63%6.45M
-63.41%12.69M
-42.44%17.79M
46.70%23.85M
141.71%27.61M
141.71%27.61M
Free cash flow
-82.64%-9.32M
67.97%-1.94M
-51.05%-5.68M
-31.61%-25.22M
-45.76%-10.3M
-32.48%-5.1M
-57.27%-6.06M
14.39%-3.76M
-70.44%-19.16M
-5.70%-7.06M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -82.45%-9.3M67.85%-1.94M-51.05%-5.68M-32.28%-25.17M-45.49%-10.28M-34.13%-5.1M-57.48%-6.04M13.16%-3.76M-69.97%-19.03M-5.70%-7.06M
Net income from continuing operations 30.84%-5.82M14.57%-5.06M-44.88%-5.85M-85.20%-25.97M-41.02%-7.59M-111.91%-8.41M-164.43%-5.93M-66.34%-4.04M24.50%-14.02M60.83%-5.38M
Depreciation and amortization 75.58%30.41K37.10%23.74K13.03%19.58K31.78%74.17K57.86%22.21K-2.01%17.32K41.15%17.32K41.16%17.32K46.11%56.28K20.11%14.07K
Change In working capital -221.49%-3.64M856.29%3M-193.36%-10.91K94.03%-356K-52.61%-2.97M3,534.27%3M78.12%-396.36K100.55%11.69K-186.14%-5.97M-128.09%-1.95M
-Change in receivables ---246.9K----------0--0--0---------63.33%49.01K--0
-Change in prepaid assets 3,134.20%251.81K96.52%112.39K10.44%-677.03K90.18%-114.49K590.40%592.6K97.34%-8.3K107.14%57.19K-446.35%-755.97K-7,064.75%-1.17M169.64%85.83K
-Change in payables and accrued expense -222.05%-3.66M752.91%2.96M-3.42%-215.97K54.31%-1.23M-74.47%-3.56M110.77%3M-240.41%-453.54K89.20%-208.84K-139.46%-2.69M-128.75%-2.04M
-Change in other current assets 0.00%10K--224.68K-9.67%882.1K145.60%986.5K--0100.84%10K--0--976.5K---2.16M--10K
Cash from discontinued investing activities
Operating cash flow -82.45%-9.3M67.85%-1.94M-51.05%-5.68M-32.28%-25.17M-45.49%-10.28M-34.13%-5.1M-57.48%-6.04M13.16%-3.76M-69.97%-19.03M-5.70%-7.06M
Investing cash flow
Cash flow from continuing investing activities -233.54%-20.65K63.54%-48.95K-18.95K88.06%-6.19K-181.36%-134.26K0
Net PPE purchase and sale -233.54%-20.65K--------63.54%-48.95K---18.95K88.06%-6.19K---------181.36%-134.26K--0
Cash from discontinued investing activities
Investing cash flow -233.54%-20.65K--------63.54%-48.95K---18.95K88.06%-6.19K---------181.36%-134.26K--0
Financing cash flow
Cash flow from continuing financing activities 16.35M-88.51%4.06M4.06M0176.54%35.35M0
Net issuance payments of debt ---150K------------------0----------------
Net common stock issuance --15.52M----------0--0--0--------194.69%27.73M--0
Proceeds from stock option exercised by employees --977.77K---------46.73%4.06M--4.06M--0--------124.02%7.63M--0
Cash from discontinued financing activities
Financing cash flow --16.35M---------88.51%4.06M--4.06M--0--------176.54%35.35M--0
Net cash flow
Beginning cash position -91.22%1.56M-96.78%768.86K-76.63%6.45M141.71%27.61M-63.41%12.69M-42.44%17.79M46.70%23.85M141.71%27.61M15.58%11.42M91.51%34.68M
Current changes in cash 237.81%7.03M113.08%792.85K-51.05%-5.68M-230.71%-21.16M11.75%-6.23M-235.17%-5.1M-141.39%-6.06M-177.84%-3.76M951.17%16.19M-5.70%-7.06M
End cash Position -32.27%8.59M-91.22%1.56M-96.78%768.86K-76.63%6.45M-76.63%6.45M-63.41%12.69M-42.44%17.79M46.70%23.85M141.71%27.61M141.71%27.61M
Free cash flow -82.64%-9.32M67.97%-1.94M-51.05%-5.68M-31.61%-25.22M-45.76%-10.3M-32.48%-5.1M-57.27%-6.06M14.39%-3.76M-70.44%-19.16M-5.70%-7.06M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Investment Theme Mpox (monkeypox)
Mpox (monkeypox)
Intraday+0.54%